INACTIVE/DISSOLVED
Address
MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States
Phone
Website
VCID: 3030
Profile
Corporate information
Investment activity status
Not investing
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Coferon Inc Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules |
United States | 1 Jul 2012 | Series B |
||
Catabasis Pharmaceuticals Inc |
United States | 1 Apr 2010 1 Dec 2011 |
Series A |
||
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. |
United States | 10 Jun 2011 | Series D |
||
Rib-X Pharmaceuticals Inc |
United States | 1 Jan 2009 | N/A |
||
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |
||
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. |
United States | 1 Oct 2008 | Seed |
||
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | 1 Mar 2008 | Series B Active |
||
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. |
United States | 25 Oct 2006 | Series C |
||
Avidia Inc |
United States | 1 May 2005 | Series B Active |
||
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. |
United States | 31 Dec 2003 | Series C |
||
Applied Genetic Technologies Corp A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. |
United States | N/A |
|||
Critical Therapeutics Inc Discoverer, developer and commercialize novel therapies. |
United States | N/A |
|||
Xencor Inc Provider of protein engineering technology platforms in the biotechnology industry. |
United States | N/A |
|||
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. |
United States | N/A |
|||
VLST Corp |
United States | N/A |
|||
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. |
United States | N/A |
|||
Synovex Corp |
United States | N/A |
|||
VaxInnate Corp |
United States | N/A |
|||
Corridor Pharmaceuticals Inc |
United States | N/A |